RenovoRx, Inc. (RNXT): Total Liabilities
$2.67M
As of 2025-12-31
$2.49M
As of 2026-06-30
+34.4%
3-year compound annual growth
-8.3%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.67M | -26.6% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $3.64M | -18.5% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $4.47M | +305.3% | 2025-04-01, Balance as of period end |
| 2022-12-31 | $1.10M | +17.5% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $938.0K | -77.2% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $4.12M | n/a | 2022-03-30, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $2.67M | -26.6% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $1.38M | -73.1% |
| SeaStar Medical Holding Corp (ICU) | 2025-12-31 | $3.74M | -45.3% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $6.58M | +19.2% |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $9.21M | -42.5% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $71.64M | +45.6% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $1.62M | +32.8% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $4.92M | +4.9% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $4.11M | -57.5% |
Compare RNXT, PETV, ICU, SINT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗